Both in Pharmaceuticals
Cartesian Therapeutics vs Keros Therapeutics
Over the past year RNAC returned −26.5% and KROS returned −29.8%; their daily moves had a correlation of 0.35.
RNAC −26.5% KROS −29.8%Growth of $1, one year, split-adjusted
| Metric | RNAC | KROS |
|---|---|---|
| Price | $7.24 | $11.19 |
| Market cap | $219.0M | $221.9M |
| Today | +0.42% | −0.80% |
| 1 month | −24.6% | +1.5% |
| 6 months | +23.1% | +4.8% |
| Year to date | +0.4% | −45.0% |
| 1 year | −21.8% | −30.3% |
| Revenue growth (YoY) | −100.0% | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 148.3× | 14.8× |
| Net cash | $94.8M | $257.6M |
| Dividend yield | — | — |
| Volatility (60d) | 48.5% | 48.2% |
| Short % of float | 15.0% | 7.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).